Google Cloud has launched two tools aimed at speeding up drug discovery and advancing precision medicine.
- The Target and Lead Identification Suite assists in identifying the functions of amino acids and predicting protein structures, while the Multiomics Suite speeds up the discovery and analysis of genomic data, according to the company's statement.
- Pfizer and Cerevel are among the firms to have embraced the Target and Lead Identification Suite, while the Multiomics Suite enables the analysis of genomics data and the designing of clinical genomics.
- Cloud agnostic, it can be used with existing investments in multiomics.
